Format

Send to

Choose Destination
Eur Respir J. 2018 Nov 8;52(5). pii: 1801254. doi: 10.1183/13993003.01254-2018. Print 2018 Nov.

Investigating unilateral pleural effusions: the role of cytology.

Author information

1
Academic Respiratory Unit, Bristol Medical School, Translational Health Sciences, Bristol, UK arnold.dta@gmail.com.
2
Academic Respiratory Unit, Bristol Medical School, Translational Health Sciences, Bristol, UK.
3
Bristol School of Anaesthesia, Bristol, UK.
4
North Bristol Lung Centre, North Bristol NHS Trust, Bristol, UK.
5
Dept of Cellular Pathology, North Bristol NHS Trust, Bristol, UK.

Abstract

The vast majority of undiagnosed unilateral pleural effusions have fluid sent for cytological analysis. Despite widespread use, there is uncertainty about its sensitivity to diagnose malignant pleural effusions (MPEs). Our aim was to ascertain the utility of cytology using a large prospective cohort.Consecutive patients presenting with an undiagnosed unilateral pleural effusion were recruited to this UK-based study. All had pleural fluid sent for cytological analysis. Cytological sensitivity was based on the final diagnosis at 12 months, confirmed by two consultants.Over 8 years, 921 patients were recruited, of which 515 had a MPE. Overall sensitivity of fluid cytology to diagnose malignancy was 46% (95% CI 42-58%). There was variation in sensitivity depending on cancer primary, with mesothelioma (6%) and haematological malignancies (40%) being significantly lower than adenocarcinomas (79%). MPEs secondary to ovarian cancer had high pick-up rates (95%). In asbestos-exposed males with exudative effusions, the risk of MPE was 60%, but cytological sensitivity was 11%.This is the largest prospective study of pleural fluid cytology and informs discussions with patients about the likely requirement for investigations following thoracentesis. In patients presenting with a clinical suspicion of mesothelioma, cytological sensitivity is low, so more definitive investigations could be performed sooner.

Conflict of interest statement

Conflict of interest: D.T. Arnold has nothing to disclose. Conflict of interest: D. De Fonseka has nothing to disclose. Conflict of interest: S. Perry has nothing to disclose. Conflict of interest: A Morley has nothing to disclose. Conflict of interest: J.E. Harvey has nothing to disclose. Conflict of interest: A. Medford has nothing to disclose. Conflict of interest: M. Brett has nothing to disclose. Conflict of interest: N.A. Maskell has nothing to disclose.

Supplemental Content

Full text links

Icon for HighWire
Loading ...
Support Center